|
Re: Merck's PIII Prostate trial, not the one with ZEN-3694, is halted for not showing improvement vs control
|
2
|
Zenith Epigenetics
|
Jan 26, 2023 07:44PM
|
|
Re: Some history
|
7
|
Resverlogix Corp.
|
Jan 25, 2023 03:10PM
|
|
Merry Christmas to all
|
8
|
Resverlogix Corp.
|
Dec 24, 2022 01:59PM
|
|
Merry Christmas to all
|
5
|
Zenith Epigenetics
|
Dec 24, 2022 01:57PM
|
|
Re: zenith trials
|
1
|
Zenith Epigenetics
|
Dec 24, 2022 01:55PM
|
|
Re: National Research Council's financially supported companies for COVID and LONG COVID
|
1
|
Resverlogix Corp.
|
Dec 09, 2022 11:00AM
|
|
Re: Vas. Dementia pipeline RVX?
|
6
|
Resverlogix Corp.
|
Dec 07, 2022 05:11PM
|
|
Re: Vas. Dementia pipeline RVX?
|
4
|
Resverlogix Corp.
|
Dec 07, 2022 01:38PM
|
|
Re: toronto appliance repair
|
1
|
Zenith Epigenetics
|
Nov 27, 2022 02:07PM
|
|
Re: Two big thank you’s
|
1
|
Zenith Epigenetics
|
Nov 25, 2022 02:23PM
|
|
Re: Two big thank you’s
|
2
|
Zenith Epigenetics
|
Nov 24, 2022 08:40PM
|
|
Re: Two big thank you’s
|
2
|
Zenith Epigenetics
|
Nov 24, 2022 07:41PM
|
|
Two big thank you’s
|
|
Zenith Epigenetics
|
Nov 24, 2022 01:46PM
|
|
Re: Potential Scope of Indications for Apabetalone (selective BRD/BD inhibition)
|
2
|
Resverlogix Corp.
|
Nov 18, 2022 09:06PM
|
|
Re: Potential Scope of Indications for Apabetalone (selective BRD/BD inhibition)
|
2
|
Resverlogix Corp.
|
Nov 15, 2022 12:21PM
|
|
Re: Potential Scope of Indications for Apabetalone (selective BRD/BD inhibition)
|
2
|
Resverlogix Corp.
|
Nov 14, 2022 05:12PM
|
|
Re: find it interesting that RVXCF.....
|
3
|
Resverlogix Corp.
|
Nov 11, 2022 07:47PM
|
|
Re: find it interesting that RVXCF.....
|
7
|
Resverlogix Corp.
|
Nov 10, 2022 07:32PM
|
|
Re: Toxicity
|
4
|
Zenith Epigenetics
|
Nov 03, 2022 04:08PM
|
|
Re: USA ZHCLF investors
|
1
|
Zenith Epigenetics
|
Nov 02, 2022 09:41PM
|
